Massachusetts sues Publicis for designing ‘marketing schemes’ to boost OxyContin sales

first_img What is it? Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+. First 30 days free. GET STARTED By Ed Silverman May 6, 2021 Reprints Pharmalot Tags opioidspharmaceuticals What’s included? Pharmalot Columnist, Senior Writer Ed covers the pharmaceutical industry. [email protected] Daily reporting and analysis The most comprehensive industry coverage from a powerhouse team of reporters Subscriber-only newsletters Daily newsletters to brief you on the most important industry news of the day STAT+ Conversations Weekly opportunities to engage with our reporters and leading industry experts in live video conversations Exclusive industry events Premium access to subscriber-only networking events around the country The best reporters in the industry The most trusted and well-connected newsroom in the health care industry And much more Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr. GET STARTEDcenter_img Toby Talbot/AP Log In | Learn More STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond. Massachusetts sues Publicis for designing ‘marketing schemes’ to boost OxyContin sales About the Author Reprints Ed Silverman @Pharmalot The Massachusetts attorney general has filed a lawsuit against Publicis Health, one of the world’s largest health care communications companies, for allegedly designing and placing unfair and deceptive “marketing schemes” to help Purdue Pharma sell more of its OxyContin painkiller.The state claimed that, from 2010 through 2019, Publicis (PUBGY) collected more than $50 million in exchange for creating plans that convinced doctors to prescribe Purdue opioids to more patients — and at higher doses for longer periods of time. As a result, Publicis helped create a “public nuisance” of opioid use disorder, overdose, and death in Massachusetts.last_img read more